Mite allergen specific yolk immunoglobulin antibody and anti-allergic preparation thereof

An allergen and specific technology, applied in the direction of egg immunoglobulin, anti-animal/human immunoglobulin, antibody, etc., can solve the problems of low patient compliance and high cost, and achieve a good barrier effect , The effect of high safety performance and high antibody activity

Inactive Publication Date: 2018-06-22
广州益琪琳生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Desensitization treatment can make about 70% of patients develop tolerance to the corresponding allergens, but the desensitization cycle is as long as

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mite allergen specific yolk immunoglobulin antibody and anti-allergic preparation thereof
  • Mite allergen specific yolk immunoglobulin antibody and anti-allergic preparation thereof
  • Mite allergen specific yolk immunoglobulin antibody and anti-allergic preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0047] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention will be further described in detail below in conjunction with specific embodiments. The embodiments described below are exemplary, and are only used to explain the present invention, but should not be construed as limiting the present invention. Where specific techniques or conditions are not indicated in the examples, the procedures shall be carried out in accordance with the techniques or conditions described in the literature in the field or in accordance with the product specification.

[0048] In the following, the mite allergen-specific egg yolk immunoglobulin antibody and its anti-allergic preparation of the present invention will be specifically described in conjunction with specific test diagrams.

[0049] The method for preparing the mite allergen-specific IgY antibody of the present invention specifically includes the following s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a mite allergen specific yolk immunoglobulin antibody and an anti-allergic preparation thereof. The mite allergen specific yolk immunoglobulin antibody is mainly prepared by the following method: extracting a mite allergen, carrying out supplementary immunization on chickens, preparing crude extract, finely extracting and purifying. The mite allergen specific yolk immunoglobulin antibody and the preparation thereof, provided by the invention, have the advantages of high antibody activity and specific defending effect on local sensitization caused by mites, and have a good rejection effect on the local sensitization caused by sensibiligen; the mite allergen specific yolk immunoglobulin antibody has no immunogenicity, no adverse effect on skin mucous membranes of human bodies and high safety performance.

Description

Technical field [0001] The invention belongs to the field of biomedicine, and relates to an egg-yolk immunoglobulin antibody and an anti-allergic preparation thereof, in particular to a mite allergen-specific egg-yolk immunoglobulin antibody and an anti-allergic preparation thereof. Background technique [0002] Allergic rhinitis (allergic rhinitis, AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mediated by IgE after the body is exposed to allergens. A large number of epidemiological surveys at home and abroad show that there are more than 500 million AR patients worldwide. AR has become a major chronic inflammatory disease of the respiratory tract, which has a serious impact on the quality of life of patients and the social economy. Faced with such a high prevalence rate and patients’ requirements for improving the quality of life, various clinical diagnosis and treatment measures have emerged. Local glucocorticoids in the nasal cavity, oral antihistam...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/18A61K39/395A61P11/02A61P37/08A61P11/06A61P17/10
CPCA61K2039/505C07K16/02C07K16/18
Inventor 谢民强
Owner 广州益琪琳生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products